We're testing a new treatment called AVZO-103, alone and with another drug, to find the safest and most effective dose. We want to see if this combination can help treat advanced solid tumors. We're also studying how your body processes and reacts to AVZO-103 to learn who might benefit most from it.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Matthew Milowsky
Lineberger Comprehensive Cancer Center
Clinical or Medical
Interventional
Cancer (Bladder)
Urinary and Bladder
25-2602
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
